IQVIA_Rules_Based_Medicine_Logo - rgb

(+01) 512 835 8026

Email us

Type your search term and press "enter."

Interleukin-10

Interleukin-10

Interleukin-10 (IL-10) is a type II cytokine with anti-inflammatory properties, IL-10 is secreted by macrophages, dendritic cells, B cells, and T cells, and modulates their functions to minimize tissue damage during acute phases of immune responses. IL-10 is a homodimer that signals through a functional receptor complex composed of two IL-10 receptor-1 proteins and two IL-10 receptor-2 proteins via STAT3, JAK1, and Tyk2. IL-10 inhibits the secretion of pro-inflammatory cytokines such as IL-1?, IL-12, IFN-?, and TNFa from TLR-activated myeloid cells after exposure to bacterial products. IL-10 promotes B cell survival, proliferation and upregulates antibody production. It decreases Th1 cytokines, MHC class II, and co-stimulatory molecules expression on macrophages. The pleiotropic role of IL-10 in immunoregulation and inflammation has been implicated in many pathogenic states including autoimmune diseases and cancer. Risk of prostate cancer has been associated with SNPs in IL-10. SNPs in the promoter region have been associated with risk of lung cancer among Asians and Caucasians. IL-10 levels are significantly increased in serum from patients with tuberculosis, and during viral infections, IL-10 triggers and modulates antiviral T cell responses. Although recombinant human IL-10 has been tested for Crohn?s disease, rheumatoid arthritis, psoriasis, hepatitis C, and HIV, the transition from testing to clinical application has been hindered by dosing and administration difficulties. In patients with advanced renal cell cancer, pegylated IL-10 has been shown to have antitumor activity.

Swiss-Prot Accession Number: P22301


Bibliography

Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus (2020) Casey KA, Smith MA, Sinibaldi D, Seto NL, Playford MP, Wang X, Carlucci PM, Wang L, Illei G, Yu B, Wang S, Remaley AT, Mehta NH, Kaplan MJ, White WI Arthritis Rheumatology

medical_services Therapy Indications

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimers disease (2020) Pillai JA, Bena J, Bebek Gurkan, Bekris LM, Bonner-Jackson A, Kou L, Pai A, Sorensen L, Neilsen M, Rao SM, Chance M, Lamb BT, Leverenz JB, Alzheimers Disease Neuroimaging Initiative Annals of Clinical and Translational Neurology

medical_services Therapy Indications

Effects of Traumeel (Tr14) on recovery and inflammatory immune response after repeated bouts of exercise: a double-blind RCT. (2017) Muders K, Pilat C, Deuster V, Frech T, Kr?ger K, Pons-Kuhnemann J, Mooren FC Eur J Appl Physiol.

medical_services Therapy Indications

A prospective assessment of the effect of aminophylline therapy on urine output and inflammation in critically ill children (2014) Tamburro RF, Thomas NJ, Ceneviva GD, Dettorre MD, Brummel GL, Lucking SE Front. Pediatr. 2:59

medical_services Therapy Indications

Mesenteric Ischemia-Reperfusion Injury up-Regulates Certain Cc, Cxc, and Xc Chemokines and Results in Multi-Organ Injury in a Time-Dependent Manner (2013) Jawa RS, Quist E, Boyer CW, Shostrom VK, Mercer DW European Cytokine Network

medical_services Therapy Indications

Increased serum ?2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus (2012) Hermansen ML, Hummelsh?j L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S Lupus. 2012 May 10. [Epub ahead of print]

medical_services Therapy Indications

Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses (2012) Joubert MK, Hokom M, Eakin C, Zhou L, Deshpande M, Baker MP, Goletz TJ, Kerwin BA, Chirmule N, Narhi LO, Jawa V J Biol Chem. 2012 Jul 20;287(30):25266-79

medical_services Therapy Indications

Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood (2012) Schmohl M, Schneiderhan-Marra N, Baur N, Hefner K, Blum M, Stein GM, Joos TO, Schmolz M Int Immunopharmacol. 2012 Dec;14(4):722-8

medical_services Therapy Indications

Type I Interferons increase host susceptibility to Trypanosoma cruzi infection (2011) Chessler AD, Caradonna KL, Dadara A, Burleigh BA Infect Immun. 2011 Mar 14. [Epub ahead of print]

medical_services Therapy Indications

A Multianalyte Profile of Serum Proteins to Screen for Toxicological Effects of Anticholinesterase Insecticides in the Rat. (2009) Gordon CJ, Ward WO Neurotoxicology 30: 377-381.

medical_services Therapy Indications

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. (2007) Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, OShea JJ, Hunter CA Nat Immunol 8: 1363-1371.

medical_services Therapy Indications

Femoral artery neointimal hyperplasia is reduced after wire injury in Ref-1+/- mice. (2007) Basi DL, Adhikari N, Mariash A, Li Q, Kao E, Mullegama SV, Hall JL Am J Physiol Heart Circ Physiol 292: H516-H521.

medical_services Therapy Indications

Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. (2006) Schilling S, Goelz S, Linker R, Luehder F, Gold R Clin Exp Immunol 145: 101-117.

medical_services Therapy Indications